In Alzheimer’s patients, ABCB1 protein levels were reduced, while NEDD4-1 protein levels were increased, suggesting NEDD4-1 as a therapeutic target for the treatment of Alzheimer’s disease. The gene discussed is NEDD4; the disease is early-onset autosomal dominant Alzheimer disease.